ABSTRACT
This study was conducted to determine the impact of dried distiller's grain with solubles (DDGS) from 192 days of gestation through 118 days of lactation on feedlot performance, carcass characteristics, Longissimus muscle (LM) fatty acids and glucose tolerance of male progeny (n = 36). Angus-Simmental heifer dams were fed diets that contained either DDGS (DG) or not (CON) formulated to provide similar daily net energy for gain but differing crude protein. In the feedlot, male progeny were fed a diet devoid of DDGS. An intravenous glucose tolerance test (IVGTT) was performed on a subset of 20 steers prior to harvest. Steers were harvested at a common 12th rib fat depth. Data were analyzed with the GLIMMIX and MIXED procedures of SAS. Performance (P ≥ 0.11) and glucose and insulin concentrations during IVGTT (P ≥ 0.24) did not differ between treatments. Dressing percentage tended to be greater (P = 0.09) in DG than CON progeny, but all other carcass characteristics did not differ (P ≥ 0.18). Progeny from DG dams had greater LM 16:2, 18:0, and 20:1 n-9 concentrations than progeny from CON dams (P ≤ 0.02). In conclusion, DDGS are a viable option for gestating and lactating beef cows.
Subject(s)
Animal Feed , Cattle/growth & development , Cattle/physiology , Diet/veterinary , Dietary Proteins/administration & dosage , Energy Intake/physiology , Fatty Acids/analysis , Fatty Acids/metabolism , Glucose Tolerance Test/veterinary , Glucose/metabolism , Lactation/physiology , Meat/analysis , Muscle, Skeletal/metabolism , Pregnancy, Animal/metabolism , Pregnancy, Animal/physiology , Zea mays , Animals , Female , Gestational Age , Insulin/metabolism , Male , Pregnancy , Weight GainABSTRACT
Two experiments evaluated a modified delivery of prostaglandin F2alpha (PGF2alpha) after a melengestrol acetate (MGA) treatment in Angus and Bos indicus x Bos taurus (BI) heifers. Experiment 1 was replicated three times with yearling BI heifers (n = 695). Heifers received MGA (0.5 mg head(-1) day(-1)) for 14 days. In Replications 1 and 2, heifers received either 25 mg of PGF2alpha im 19 days after MGA (single) or 12.5 mg of PGF2alpha im 19 and 20 days after MGA (split). In Replication 3, heifers received the same treatments, with PGF2alpha initiated either 18 or 19 days after MGA. Estrus was detected for 72 h after PGF2alpha, with AI commencing 8-12 h after a detected estrus. Heifers not observed in estrus by 72 h were timed-AI concomitant with GnRH (100 microg im). Heifers from Replication 2 (n = 146) had blood samples collected at the initial PGF2alpha and at timed-AI to determine corpus luteum (CL) regression by evaluating plasma progesterone concentrations. The interval from MGA withdrawal to PGF2alpha did not have a significant effect on any variable in Replication 3 and there were no treatment by replication effects for any variables, therefore data were pooled. Modifying the PGF2alpha treatment from a single treatment to two treatments on consecutive days increased (P < 0.05) 72 h estrous response (43.2% versus 50.1%), timed-AI (23.9% versus 33.5%) and total-AI pregnancy rates (34.5% versus 42.5%), and CL regression (79.1% versus 92.5%), respectively. In Experiment 2, yearling Angus (n = 66) and 2-year-old BI (n = 68) heifers were synchronized as per Experiment 1 (with the initial PGF2alpha 19 days after MGA). Neither breed nor PGF2alpha treatment effected (P > 0.05) 72 h estrous response, total-AI pregnancy rate, or CL regression rate. In conclusion, treating yearling BI heifers with split treatments of PGF2alpha (given on two consecutive days) improved estrous response and pregnancy rates by increasing PGF2alpha-induced luteolysis.
